RE:RE:RE:OTC I'm going to be honest, Bohemian ...comparing stocks is a dangerous game as in most cases it's comparing apples to oranges (I hold shares of Empower). The 2020 number you refer to is for Q3 2020, Q2 was almost $1 million (sedar). Empower is a completely different company that hasn't released their 2020 annual financials yet. I expect it will rival SCRN. Their Q1 2021 could be around $10 million.
BUT, that's not the point, SCRN is a great company not because it may or may not be similar to something else but because it has solid financials, is expanding, has analyses that are positive and as such appears to be checking off all the boxes ....in spite of its dismal showing on the exchange. It seems impossible for this sp to be held down much longer
GLTY and GLTE ....exhibiting incredible patience!!! Have a great night.
bohemian62 wrote: Empower Clinics relatively same float and trading at .58 at one time hitting a 52 week high of 2.50 in February of this year . I believe SCRN revenue is much higher .
2020 Total revenues 642,744